Characterization of muscarinic receptors in the human melanoma cell line SK-Mel-28 via calcium mobilization

Cancer Letters

Volumn 133, Issue 1, 1998, Pages 107-114

  Noda, S ^a   Lammerding Koppel M ^a   Oettling, G ^a   Drews, U ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acetylcholine; Calcium mobilization; Melanoma; Muscarinic acetylcholine receptors; SK Mel 28

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; CARBACHOL; METHOCTRAMINE; MUSCARINIC RECEPTOR; PILOCARPINE; PIRENZEPINE;

ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MELANOMA CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ATROPINE; CALCIUM; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MUSCARINIC AGONISTS; RECEPTORS, MUSCARINIC; TUMOR CELLS, CULTURED;

EID: 0345435110     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00215-8     Document Type: Article

References (25)

1. André C., Guillet T.G., De Backer T.P., Vanderheyden P., Hoebeke T., Strosberg A.D. Monoclonal antibodies against the native or denatured forms of muscarinic receptors. EMBO J. 3:1984;17-21.
2. Ashkenazi A., Ramachandran J., Capon D.J. Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes. Nature. 340:1989;146-150.
3. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:1989;469-476.
4. Carey T.E., Takahashi T., Resnick L.A., Oettgen H.F., Old L.J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. USA. 73:1976;3278-3282.
5. Drews U. Cholinesterase in embryonic development. Prog. Histochem. Cytochem. 7:(3):1975;1-52.
6. Dörje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256:1991;727-733.
7. Eglen R.M., Harris G.C. Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro. Br. J. Pharmacol. 109:1993;946-952.
8. Eglen R.M., Reddy H., Watson N., Challiss R.A.T. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol. Sci. 15:1994;114-119.
9. Ford A.P.D.W., Levine W.B., Baxter G.S., Eglen R.M., Whiting R.L., Pharmacological biochemical. molecular characterization of muscarinic receptors in the guinea-pig ileum: a multidisciplinary study. Mol. Neuropharmacol. 1:1991;117-127.
10. Gutkind J.S., Novotny E.A., Brann M.R., Robbins K.C. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc. Natl. Acad. Sci. USA. 88:1991;4703.
11. Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
12. Kohn E.C., Alessandro R., Probst J., Jacobs W., Brilley E., Felder C.C. Identification and molecular characterization of a m5 muscarinic receptor in A2058 human melanoma cells. Coupling to inhibition of adenylyl cyclase and stimulation of phospholipase A2. J. Cell Biol. 271:(29):1996;17476-17484.
13. Lammerding-Köppel M., Drews U. Neural crest cells exhibit a muscarinic cholinergic system during migration. Ann. Anat. 175:(Suppl.):1993;19.
14. Lammerding-Köppel M., Noda S., Blum A., Schaumburg-Lever G., Rassner G., Drews U. Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas. J. Cutan. Pathol. 25:1997;137-144.
15. Oettling G., Schmidt H., Drews U. The muscarinic receptor of chick embryo cells: correlation between ligand binding and calcium mobilization. J. Cell Biol. 100:1985;1073-1081.
16. Oettling G., Bruchelt G., Lohmann F., Teufel M., Niethammer D., Treuner J., Drews U. Vasoactive intestinal polypeptide (VIP) induces calcium mobilization in the human neuroblastoma cell line SK-N-SH. Cancer Lett. 50:1990;203-207.
17. Oettling G., Götz U., Drews U. Characterization of the Ca2+ influx into embryonic cells after stimulation of the embryonic muscarinic receptor. J. Dev. Physiol. 17:1992;147-153.
18. Razon N., Soreq H., Roth E., Bartal A., Silman I. Characterization of activities and forms of cholinesterases in human primary brain tumors. Exp. Neurol. 84:1984;681-695.
19. Rösner H., Vacun G., Rebhan M. Muscarinic receptor-mediated induction of actin-driven lamellar protrusions in neuroblastoma cell somata and growth cones. Involvement of protein kinase C. Eur. J. Cell Biol. 66:1995;324-334.
20. Soreq H., Lapidot-Lifson Y., Zakut H. A role of cholinesterases in tumorigenesis? Cancer Cells. 3:1991;511.
21. Soreq H., Zakut H. Amplification of butyrylcholinesterase and acetylcholinesterase genes in normal and tumor tissues: putative relationship to organophosphorus poisoning. Pharmaceut. Res. 7:1990;1.
22. Thomas E.A., Baker S.A., Ehlert F.J. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol. Pharmacol. 44:1993;102-110.
23. Thomas E.A., Hsu H.H., Griffin M.T., Hunter A.L., Luong T., Ehlert F.J. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues. Mol. Pharmacol. 41:1992;718-726.
24. Williams C.L., Hayes V.Y., Hummel A.M., Tarara J.E., Halsey T.J. Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma. J. Cell Biol. 121:1993;643-654.
25. Zakut H., Ehrlich G., Ayalon A., Prody C.A., Malinger G., Seidman S., Ginzberg D., Kehlenbach R., Soreq H. Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas. J. Clin. Invest. 86:1990;900-908.